| Kelly C Yates, | |
|
1501 Rainbow Rd, Rogers, AR 72758-1481 | |
| (479) 521-8326 | |
| (479) 521-5439 |
| Full Name | Kelly C Yates |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1501 Rainbow Rd, Rogers, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093047649 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | O-T1004 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly C Yates, 1501 Rainbow Rd, Rogers, AR 72758-1481 Ph: (479) 521-8326 | Kelly C Yates, 1501 Rainbow Rd, Rogers, AR 72758-1481 Ph: (479) 521-8326 |
News Archive
New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1
Caudate hepatocellular carcinoma (HCC) has a poorer prognosis than HCC originating from other lobes, due to its proximity to the portal trunk and inferior vena cava, which facilitate intrahepatic and systemic spread early in the disease. Hepatic resection is considered, in principle, to be the first choice treatment. In order to improve surgical outcome, it is necessary to evaluate the potential risk factors affecting long-term survival and to establish guidelines for the appropriate use of hepatectomy for caudate lobectomy.
Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system.
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained favorable results from recently completed Phase 1 studies of LX4211 and announced today that it has initiated a Phase 2 clinical trial of the drug candidate in patients with type 2 diabetes mellitus.
› Verified 1 days ago
Sarah Jordan Reeves, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 2510 W Hudson Rd, Rogers, AR 72756 Phone: 479-936-1061 | |
Britney Lamont, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 W Poplar St, Rogers, AR 72756 Phone: 479-631-7678 | |
Dr. Adelline Grace Posey Maddux, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 W Poplar St, Rogers, AR 72756 Phone: 479-631-7678 Fax: 479-631-8886 | |
Anna Elizabeth Porta, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4804 W Red Maple Ct, Rogers, AR 72758 Phone: 479-466-7136 | |
Katelyn Estelle Simmons, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2510 W Hudson Rd, Rogers, AR 72756 Phone: 479-936-1061 Fax: 855-812-1132 | |
Sabrina Elisabeth Mashburn, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 W Poplar St, Rogers, AR 72756 Phone: 479-631-7678 |